New York TimesUPDATE 2-Express Scripts drops Gilead hep C drugs for cheaper AbbVie rivalReuters(Adds broader impact on biotechnology stocks). By Caroline Humer. Dec 22 (Reuters) - The largest U.S. pharmacy benefit manager said on Monday it has lined up a cheaper price for AbbVie Inc's newly approved hepatitis C treatment and, in most cases, will ...Express Scripts turns to AbbVie in huge hepatitis C dealThe Seattle TimesAbbVie lowers price of hepatitis C drug to win deal with Express ScriptsChicago TribuneGilead slides after hepatitis drug setbackFinancial TimesBusinessweek -Forbes -Philly.comall 217 news articles »

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News